Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-395827

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Gary Charles Robb
Officer — Chief Business Officer
Period of report
Sep 17, 2026
Accepted (ET)
Sep 18, 2026 · 7:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001088856

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 17, 2026M17,493$8.27A31,156D
Common StockF2holding———39,716IGary Charles Robb TTE Robb Revocable Trust
Common StockF3holding———15,571ICustodial Account for Child
Common StockF4holding———15,571ICustodial Account for Child

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock option (right to buy)F5$8.27Sep 17, 2026M17,493D—Feb 10, 2027Common Stock17,493182,507D

Explanation of responses

Remarks

The power of attorney under which this form was signed is on file with the Commission.